BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32006415)

  • 1. CRISPR/Cas9-Mediated Genome Engineering of Primary Human B Cells.
    Laoharawee K; Johnson MJ; Moriarity BS
    Methods Mol Biol; 2020; 2115():435-444. PubMed ID: 32006415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-Mediated Genome Editing in Epstein-Barr Virus-Transformed Lymphoblastoid B-Cell Lines.
    Jiang S; Wang LW; Walsh MJ; Trudeau SJ; Gerdt C; Zhao B; Gewurz BE
    Curr Protoc Mol Biol; 2018 Jan; 121():31.12.1-31.12.23. PubMed ID: 29337376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly Multiplexed Analysis of CRISPR Genome Editing Outcomes in Mammalian Cells.
    Ishiguro S; Yachie N
    Methods Mol Biol; 2021; 2312():193-223. PubMed ID: 34228292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and efficient generation of antigen-specific isogenic T cells from cryopreserved blood samples.
    Eerkens AL; Vledder A; van Rooij N; Foijer F; Nijman HW; de Bruyn M
    Immunol Cell Biol; 2022 Apr; 100(4):285-295. PubMed ID: 35194830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches for CRISPR/Cas9 Genome Editing in C. elegans.
    Martin CJ; Calarco JA
    Methods Mol Biol; 2022; 2468():215-237. PubMed ID: 35320567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CRISPR Landing for Genome Rewriting at Locus-Scale.
    Hughes NW; Cong L
    CRISPR J; 2021 Apr; 4(2):163-166. PubMed ID: 33876954
    [No Abstract]   [Full Text] [Related]  

  • 7. CRISPR/Cas9-Mediated In Vitro Mutagenesis in GC-Like B Cells.
    Chu VT; Graf R; Rajewsky K
    Methods Mol Biol; 2017; 1623():135-145. PubMed ID: 28589354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9-mediated editing of DMR6 orthologue in banana (Musa spp.) confers enhanced resistance to bacterial disease.
    Tripathi JN; Ntui VO; Shah T; Tripathi L
    Plant Biotechnol J; 2021 Jul; 19(7):1291-1293. PubMed ID: 33934462
    [No Abstract]   [Full Text] [Related]  

  • 9. Engineering of Multiple Modules to Improve Amorphadiene Production in
    Song Y; He S; Abdallah II; Jopkiewicz A; Setroikromo R; van Merkerk R; Tepper PG; Quax WJ
    J Agric Food Chem; 2021 Apr; 69(16):4785-4794. PubMed ID: 33877851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Catalogue of Cas9 Orthologs to Advance Genome Engineering.
    Wang E; Hsu PD
    CRISPR J; 2020 Dec; 3(6):427-430. PubMed ID: 33346708
    [No Abstract]   [Full Text] [Related]  

  • 11. Orthotopic T-cell receptor replacement in primary human T cells using CRISPR-Cas9-mediated homology-directed repair.
    Moosmann C; Müller TR; Busch DH; Schober K
    STAR Protoc; 2022 Mar; 3(1):101031. PubMed ID: 34977677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of fatty acid productivity of thraustochytrid, Aurantiochytrium sp. by genome editing.
    Watanabe K; Perez CMT; Kitahori T; Hata K; Aoi M; Takahashi H; Sakuma T; Okamura Y; Nakashimada Y; Yamamoto T; Matsuyama K; Mayuzumi S; Aki T
    J Biosci Bioeng; 2021 Apr; 131(4):373-380. PubMed ID: 33386277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful correction of hemophilia by CRISPR/Cas9 genome editing in vivo: delivery vector and immune responses are the key to success.
    Nguyen TH; Anegon I
    EMBO Mol Med; 2016 May; 8(5):439-41. PubMed ID: 27138565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome editing of human pancreatic beta cell models: problems, possibilities and outlook.
    Balboa D; Prasad RB; Groop L; Otonkoski T
    Diabetologia; 2019 Aug; 62(8):1329-1336. PubMed ID: 31161346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR -Cas9: a groundbreaking new technique which ushers in new prospects and just as many doubts.
    Napoletano S; Piersanti V; Rallo G
    Clin Ter; 2021; 171(1):e52-e54. PubMed ID: 33346327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity maturation of CRISPR-engineered B cell receptors in vivo.
    Nat Biomed Eng; 2024 Apr; 8(4):341-342. PubMed ID: 38509393
    [No Abstract]   [Full Text] [Related]  

  • 17. Too Much Compromise in Today's CRISPR Pipelines.
    Fox R
    CRISPR J; 2019 Jun; 2(3):143-145. PubMed ID: 31225751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Editing of Human Embryos with CRISPR/Cas9: Great Promise Coupled with Important Caveats.
    Schenkwein D; Ylä-Herttuala S
    Mol Ther; 2018 Mar; 26(3):659-660. PubMed ID: 29477495
    [No Abstract]   [Full Text] [Related]  

  • 19. The evolving CRISPR technology.
    Yan M; Li J
    Protein Cell; 2019 Nov; 10(11):783-786. PubMed ID: 31243729
    [No Abstract]   [Full Text] [Related]  

  • 20.
    Qi S
    CRISPR J; 2020 Jun; 3(3):135. PubMed ID: 33560911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.